Competitors are following suit. Danone has launched Oikos Fusion, a 7-ounce cultured dairy drink packing 23 grams of protein and 5 grams of prebiotic fiber, explicitly targeting GLP-1 users. The broader packaged-food sector is racing to adapt to a consumer base that eats roughly 50% less volume but requires every bite to be nutrient-dense, particularly for muscle preservation and digestive health.
For Nestlé, the financial contribution of the new lines remains unquantified in public disclosures. The company's shares traded at a two-year low in October 2023 as investors weighed the potential for GLP-1 drugs to suppress overall packaged-food volumes. Whether the companion-nutrition strategy can offset that volume decline — or merely mitigate it — will depend on adoption rates, pricing power, and the durability of GLP-1 usage patterns. Can Nestlé's early-mover advantage in GLP-1 companion nutrition translate into a measurable revenue stream before the market saturates?
Sources: Source 1 · Source 2 · Source 3 · Source 4 · Source 5 · Source 6
